Amoxicillin: Nursing Drug Guide, Penicillin Allergy & NCLEX Review
Before the first dose, verify beta-lactam allergy history, recognize urticaria and anaphylaxis early, avoid empiric use when infectious mononucleosis is suspected, and adjust renal dosing when GFR is below 30 mL/min.
Serious and occasionally fatal anaphylactic reactions have occurred with oral penicillins including amoxicillin. Amoxicillin is contraindicated after a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin or other beta-lactams. Before the first dose, obtain a careful allergy history for penicillins, cephalosporins, and other allergens; clarify vague childhood rash stories with the prescriber or pharmacist. If urticaria, angioedema, bronchospasm, or hypotension develops, stop the drug immediately and treat per facility anaphylaxis protocol—do not rechallenge without allergy specialist guidance.
📋 Contents
⚡ Quick facts
💡 Key takeaway
Never give amoxicillin until penicillin and beta-lactam allergy history is verified and documented—treat vague childhood rash as a safety stop, not a formality. At the first sign of urticaria, facial swelling, wheeze, or hypotension after a dose, hold the drug and escalate for anaphylaxis management before the next scheduled dose.
Most common brand names
Amoxicillin is widely available as generic capsules and suspensions. Confirm the ordered strength (250 mg or 500 mg capsules per labeling) and that the patient can swallow oral therapy.
Common brand names include Amoxil and Moxatag (extended-release, where stocked). Combination products (e.g., amoxicillin/clavulanate) are separate orders—do not substitute without prescriber and pharmacy approval.
Why we give it — Indications
Amoxicillin is a penicillin-class antibacterial used for susceptible infections of the ear, nose, throat, genitourinary tract, skin, and lower respiratory tract per FDA-approved labeling. Nurses most often administer it for community-acquired infections such as sinusitis, streptococcal pharyngitis (when ordered), urinary tract infection, skin structure infection, and pneumonia when the organism is susceptible.
| Use | Detail |
|---|---|
| Ear, nose, throat | Indicated for infections of the ear, nose, and throat when susceptible organisms are identified or empirically appropriate per prescriber plan. |
| Genitourinary tract | Indicated for genitourinary infections including uncomplicated UTI when culture or local guidelines support beta-lactam therapy. |
| Skin and skin structure | Used for susceptible skin infections; coordinate with wound care and culture results when available. |
| Lower respiratory tract | Indicated for lower respiratory infections; continue therapy at least 48–72 hours beyond symptom resolution or documented eradication per labeling. |
| Streptococcus pyogenes | At least 10 days of therapy is recommended to help prevent acute rheumatic fever when treating group A streptococcal infection. |
On a small screen, swipe or scroll sideways to see the full table.
Amoxicillin treats bacterial infections only; it does not treat viral illness such as infectious mononucleosis—and may cause a high rate of rash in those patients.
How it works
Amoxicillin is an antibacterial drug that inhibits bacterial cell-wall synthesis (beta-lactam mechanism). It is stable in gastric acid and is rapidly absorbed after oral administration. Because it is excreted largely unchanged in urine, renal function affects dosing interval in severe impairment.
Dosing overview
Adult and pediatric patients older than 3 months are dosed by infection severity per Table 1 in the prescribing information. Verify every order against indication, weight (children under 40 kg), and renal function before administration.
Duration: Continue a minimum of 48–72 hours beyond when the patient becomes asymptomatic or bacterial eradication is documented; S. pyogenes infections require at least 10 days. Some infections need several weeks—follow prescriber and culture guidance.
Missed dose: Not specified in the reviewed prescribing information for routine oral therapy. Do not double doses; give the next dose only if the interval allows and the prescriber/pharmacist confirms the plan.
Onset, peak, duration, and half-life
| Parameter | Value | Nursing relevance |
|---|---|---|
| Absorption | Stable in gastric acid; rapidly absorbed orally | May give without regard to meals unless local protocol specifies otherwise |
| Peak (250 / 500 mg) | 3.5–5 and 5.5–7.5 mcg/mL at 1–2 h | Onset of antibacterial effect is not immediate—reassess clinical response on subsequent shifts |
| Half-life | 61.3 minutes (label average) | Renal elimination predominates; impaired renal function prolongs exposure |
| Excretion | ~60% unchanged in urine within 6–8 h | Review eGFR before high-dose or 875 mg regimens |
| Detectable serum | Up to 8 h after oral dose | Missed doses and interval errors affect tissue levels—document actual administration times |
On a small screen, swipe or scroll sideways to see the full table.
Before you give it — Safety check
Pretreatment checks
- Allergy history: penicillins, cephalosporins, carbapenems, and other beta-lactams; ask about anaphylaxis, angioedema, Stevens-Johnson syndrome, and timing of prior reactions
- Complete medication reconciliation for interacting drugs (oral anticoagulants, allopurinol, probenecid, oral contraceptives)
- Review renal function when severe impairment is possible; confirm dose if GFR <30 mL/min
- Screen for infectious mononucleosis when clinically suspected—labeling advises against administration in mononucleosis because of high rash incidence
- Confirm bacterial indication; antiviral illness with fever alone does not justify empiric antibiotic use without prescriber plan
Contraindications
- Serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin or other beta-lactam antibiotics
- Active hypersensitivity during therapy—discontinue at first rash or systemic allergy sign per labeling
Important interactions
| Drug / class | Effect | Nursing action |
|---|---|---|
| Warfarin / oral anticoagulants | May prolong prothrombin time (INR) | Monitor INR when amoxicillin is added or stopped; report bleeding or supratherapeutic INR |
| Allopurinol | Increased incidence of rash versus amoxicillin alone | Teach patients to report new rash promptly; differentiate from allergy |
| Probenecid | Delays renal excretion of amoxicillin | Notify pharmacist if probenecid starts or stops during therapy |
| Other antibacterials | May alter gut flora and raise C. difficile risk | Monitor for watery diarrhea during and up to 2 months after therapy |
On a small screen, swipe or scroll sideways to see the full table.
Administration
Route: Oral capsules (250 mg and 500 mg amoxicillin as trihydrate per labeling).
- Follow medication administration rights; verify patient identity, drug, dose, route, time, and allergy band
- Capsules may be taken with or without food unless prescriber specifies otherwise
- Document exact time given to support interval dosing and culture follow-up
- Do not crush or open capsules unless pharmacy provides an approved alternative formulation
Expected therapeutic response
- Defervescence and improving symptoms of bacterial infection (e.g., decreasing purulent drainage, improving dysuria, reduced sore throat severity) after 48–72 hours
- Stable or improving vital signs without new allergic findings
- Culture or clinical follow-up supports continued therapy when ordered for longer courses
Lack of improvement after 72 hours may indicate resistant organisms or nonbacterial illness—notify prescriber rather than assuming nonadherence alone.
Adverse effects
| Adverse effect | Frequency / severity | Nursing response |
|---|---|---|
| Diarrhea, rash, vomiting, nausea | Most common (>1%) in clinical trials | Supportive care; hold and escalate if severe, bloody, or with systemic allergy signs |
| Anaphylaxis / serious hypersensitivity | Serious; reported with penicillins | Stop drug; treat per anaphylaxis protocol; never rechallenge without specialist plan |
| Drug-induced enterocolitis syndrome (DIES) | Reported with amoxicillin | Protracted vomiting in infant/child—discontinue and institute appropriate therapy per labeling |
| C. difficile-associated diarrhea | Can occur during or after therapy | Hold antibiotic; contact prescriber; isolation and stool studies per protocol |
| Maculopapular rash in mononucleosis | High percentage when drug given in mononucleosis | Do not administer if mononucleosis is known or strongly suspected |
| Hepatic / hematologic effects | Postmarketing reports | Monitor LFTs or CBC if ordered; report jaundice, petechiae, or prolonged bleeding |
On a small screen, swipe or scroll sideways to see the full table.
Overdose and toxicity
In case of overdosage, discontinue medication, treat symptomatically, and institute supportive measures as required. A prospective pediatric poison-center study suggested that ingestions under 250 mg/kg were not associated with significant clinical symptoms in that cohort—still contact local poison control or toxicology services per facility protocol for any suspected overdose.
Renal crystalluria
High urine concentrations may contribute to crystalluria—maintain hydration when clinically appropriate and monitor renal function in overdose or prolonged high-dose therapy.
Contact your facility’s poison control or medical toxicology service per local protocol for large ingestions, protracted vomiting, or uncertainty about total dose taken.
Look-alike / sound-alike and error prevention
- Amoxicillin vs amoxicillin/clavulanate — verify whether clavulanate is part of the order; different allergy and GI risk profiles
- Amoxicillin vs ampicillin — similar names and class; confirm correct drug on MAR and pharmacy label
- Amoxicillin vs amitriptyline / other “amox-” prefixes — read full drug name on blister packs and automated dispensing cabinets
- 875 mg vs 500 mg — high-strength tablets given to patients with GFR <30 mL/min is a common renal dosing error
- Allergy band not updated — after any reaction, ensure allergy record reflects beta-lactam status before future antibiotic orders
Practical bedside notes
| Topic | Bedside guidance |
|---|---|
| Allergy interview | Ask what happened (hives, lip swelling, wheeze, hypotension), when, and whether the patient was re-exposed; “rash as a child” needs prescriber/pharmacy clarification |
| First-dose watch | Stay available after the first dose when allergy history is uncertain; know location of emergency equipment per unit protocol |
| Mononucleosis screen | Sore throat + splenomegaly, fatigue, posterior cervical nodes—hold empiric amoxicillin until EBV/mono status clarified when clinically suspected |
| Diarrhea teaching | Watery stools during or after therapy may be C. difficile—do not treat with antidiarrheals alone without prescriber guidance |
| Renal dosing | Pharmacy should adjust 875 mg orders when GFR <30 mL/min—nurses verify MAR matches renal function |
| Ask pharmacy when | Unclear allergy history, new warfarin or allopurinol, pregnancy/lactation questions, or recurrent rash on therapy |
On a small screen, swipe or scroll sideways to see the full table.
Red flags — Stop and act
Penicillin hypersensitivity can progress rapidly. Hold amoxicillin and escalate immediately when any of the following appear.
- Anaphylaxis symptoms: urticaria, angioedema, bronchospasm, stridor, hypotension, or syncope after a dose
- Generalized rash with mucosal involvement, blistering, or target lesions (possible Stevens-Johnson syndrome / TEN)
- Protracted vomiting in an infant or young child on amoxicillin—consider drug-induced enterocolitis syndrome
- Watery, bloody diarrhea with abdominal cramping—suspect C. difficile-associated diarrhea
- Worsening respiratory status or sepsis despite 72 hours of appropriate therapy—notify prescriber; culture and alternate therapy may be needed
High-risk populations
| Population | Considerations |
|---|---|
| Multiple allergen history | Anaphylaxis more likely in individuals with penicillin hypersensitivity and/or multiple allergies per labeling |
| Cephalosporin allergy | Severe reactions reported in some patients with penicillin allergy treated with cephalosporins—coordinate with allergy service |
| Infectious mononucleosis | High rash rate—amoxicillin should not be administered |
| Severe renal impairment (GFR <30) | No 875 mg doses; extend interval to q12h or q24h per severity and dialysis status |
| Neonates ≤12 weeks | Immature renal elimination—modified pediatric dosing per labeling |
| Pregnancy | Animal studies showed no fetal harm at high doses, but adequate human studies are lacking—use only if clearly needed |
| Lactation | Excreted in human milk; may sensitize infants—use caution |
On a small screen, swipe or scroll sideways to see the full table.
Monitoring and documentation
Monitor
- Allergy signs for at least the first dose and whenever therapy restarts after interruption
- GI tolerance: diarrhea frequency, blood in stool, abdominal pain
- Clinical response to infection (temperature, pain, wound appearance, dysuria resolution)
- INR in patients on warfarin; renal function when prolonged courses or high doses are used
Document
- Allergy verification source (patient, family, chart, allergy service)
- Dose, route, time, and indication; renal dose adjustments confirmed with pharmacy
- Any reaction with onset time, interventions, and prescriber notification
Patient teaching
- Take the full course unless the prescriber stops early—stopping early can fail treatment and promote resistance
- Report rash, hives, lip or tongue swelling, trouble breathing, or dizziness immediately—do not take another dose first
- Expect mild diarrhea sometimes; report watery or bloody stools, severe abdominal pain, or fever
- Tell clinicians about all medicines including allopurinol and warfarin; ask before starting new prescriptions
- Oral contraceptives may be less effective during amoxicillin—discuss backup methods with prescriber/pharmacist per labeling
The Hold Rule
- Documented serious beta-lactam hypersensitivity (anaphylaxis, Stevens-Johnson syndrome, or prescriber-listed contraindication)
- New urticaria, angioedema, wheeze, hypotension, or other anaphylaxis symptoms after any dose
- Suspected or confirmed infectious mononucleosis
- 875 mg dose ordered when GFR is <30 mL/min until pharmacy adjusts
- Watery bloody diarrhea or severe protracted vomiting—hold and notify prescriber
- Unclear or conflicting allergy documentation—clarify with pharmacist or prescriber before first dose
Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.
Clinical practice integration and workflow
Amoxicillin is one of the most frequently prescribed antibiotics—and one of the most common causes of antibiotic allergy alerts. Build allergy verification into every antibiotic pass, not only on admission.
1. Check-before-you-give protocol
- Right patient, drug, dose, route, time—and verified beta-lactam allergy status
- Read allergy band and chart; reconcile home antibiotics and recent courses
- Confirm renal dose when GFR <30 mL/min or on dialysis
- Screen for mononucleosis features before empiric use for pharyngitis
2. High-alert and safety badge
Allergy risk — treat first doses like high-stakes administrationAlthough not a traditional high-alert medication on all lists, anaphylaxis is life-threatening and can occur with oral penicillins. Know unit anaphylaxis response per facility protocol.
3. Clinical workflow: hold and question rules
- Stop the dose when any systemic allergy sign appears—do not “finish the course” after urticaria
- Question empiric orders for viral syndromes; align with culture and local stewardship guidance
- Escalate lack of clinical improvement after 72 hours for culture review and alternate therapy
4. Critical teach-back questions
- “What allergy symptoms should you report right away?” (Hives, swelling, breathing trouble, dizziness.)
- “Why must you finish the course unless told to stop?” (Reduce relapse and resistance; unless allergic reaction occurs.)
5. Care coordination
Pharmacist: Allergy clarification, renal dose adjustment, interaction checks with warfarin and allopurinol, and antibiotic selection if penicillin allergy is confirmed.
Prescriber / allergy service: Notify for any systemic reaction, recurrent rash, or need for alternative antibiotic class.
🧠 Quick mental checklist
- Is beta-lactam allergy history verified—not just “PCN allergy” on the band?
- Any lip swelling, hives, wheeze, or hypotension after the last dose?
- Could this be mononucleosis instead of bacterial pharyngitis?
- Is GFR <30 and is 875 mg still on the MAR?
- Watery or bloody diarrhea developing during therapy?
Amoxicillin NCLEX practice questions
This NCLEX-style clinical judgment practice set for amoxicillin uses a tabbed inpatient case (MAR, labs, history, nursing notes), then rotates priority action, cue recognition (SATA), trend interpretation, matrix urgency sorting, allergy-escalation judgment, and documentation cloze—recognise cues → analyse → prioritise → act → evaluate outcomes.
Select a tab to view MAR, labs, history, and nursing note details for this case.
- Amoxicillin 500 mg PO q8h scheduled — 0800 dose given; 1600 dose due
- Acetaminophen 650 mg PO q6h PRN fever — 1 dose at 1100
- Warfarin 5 mg PO daily — held this morning per protocol; INR due
- Allopurinol 300 mg PO daily — continued
- Admission: WBC 11.2 ×10⁹/L; temp 38.4 °C
- eGFR 24 mL/min/1.73 m² (chronic kidney disease stage 4)
- INR 2.8 (on warfarin; therapeutic range 2–3 per chart)
- Blood cultures drawn 0700 — preliminary: no growth at 12 h
- 68-year-old admitted with community-acquired pneumonia; SpO₂ 94% on 2 L nasal cannula
- Allergy band: “penicillin — rash as a child” (no documentation of anaphylaxis)
- Home meds: warfarin, allopurinol for gout
- No prior epinephrine use; no allergy consult on chart
- 0815: Tolerated 0800 amoxicillin; no immediate reaction
- 1545: New pruritic wheals on trunk and arms; BP 98/58; mild audible wheeze; patient anxious
- 1550: Nurse paused 1600 dose; notified RN charge and prescriber; preparing emergency response per protocol
Answer key & rationale
Frequently asked questions
What must I check before giving amoxicillin?
Verify a detailed allergy history for penicillins, cephalosporins, and other beta-lactams; clarify vague childhood rash stories with the prescriber or pharmacist. Confirm indication is bacterial, review renal function when severe impairment is possible, reconcile interacting drugs such as warfarin and allopurinol, and screen for infectious mononucleosis before empiric use when clinically suspected.
When should a nurse hold amoxicillin?
Hold and contact the prescriber or pharmacist for documented serious beta-lactam hypersensitivity including anaphylaxis or Stevens-Johnson syndrome, new urticaria or anaphylaxis symptoms after a dose, suspected mononucleosis, severe renal impairment when an 875 mg dose is ordered, watery bloody diarrhea suggesting C. difficile, or any unclear allergy documentation.
Can patients with a childhood penicillin rash receive amoxicillin?
Labeling warns that serious hypersensitivity can occur and that reactions are more likely in individuals with penicillin hypersensitivity history. Many childhood rashes are not IgE-mediated anaphylaxis, but nurses must not independently clear allergy—obtain prescriber or pharmacist/allergy guidance before the first dose.
Does amoxicillin need renal dose adjustment?
Mild to moderate renal impairment usually does not require dose change unless impairment is severe. When GFR is less than 30 mL/min, do not give 875 mg doses; use 500 mg or 250 mg every 12 or 24 hours depending on infection severity and dialysis status per prescribing information.
Why is rash common in mononucleosis?
A high percentage of patients with mononucleosis who receive amoxicillin develop an erythematous skin rash; labeling states amoxicillin should not be administered to patients with mononucleosis.
Is amoxicillin safe in pregnancy and breastfeeding?
Animal reproduction studies showed no fetal harm at high doses, but adequate controlled studies in pregnant women are lacking—use during pregnancy only if clearly needed. Amoxicillin is excreted in human milk and may sensitize infants; caution is advised during lactation.
References
-
U.S. National Library of Medicine. Amoxicillin capsules — Full prescribing information. DailyMed.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42f935ca-45ba-4b3e-8b40-9b2d4eb56281
-
National Institute for Health and Care Excellence. Amoxicillin. BNF.https://bnf.nice.org.uk/drugs/amoxicillin/
-
Drugs and Lactation Database (LactMed). Amoxicillin. Bethesda (MD): National Institute of Child Health and Human Development.https://www.ncbi.nlm.nih.gov/books/NBK501922/
-
U.S. National Library of Medicine. Amoxicillin. MedlinePlus.https://medlineplus.gov/druginfo/meds/a685001.html
-
Centers for Disease Control and Prevention. Antibiotic Do’s & Don’ts.https://www.cdc.gov/antibiotic-use/about/index.html
Review and transparency
This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.
Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.